Medicines360 and the Population Council Pursue Agreement to Develop Product to Prevent HIV and Unintended Pregnancy for Worldwide Distribution

Expediting development, regulatory, and manufacturing pathways of new multipurpose prevention technology for women.

New Study Challenges the Link Between Access to Menstrual Health Products and Improved Education Outcomes

Distribution of sanitary pads did not impact school attendance, but adolescent health education improved attitudes toward reproductive health.

New Report Details Impact of COVID-19 on Adolescents in Kenya

Critical need for bold action to address negative consequences of the pandemic for adolescents in Kenya.

New Council Research Shows Inconsistent and Incomplete Reporting of Key Sociodemographic Data on COVID-19 in the U.S.

Inconsistent and incomplete data expose the country’s inability to analyze and use data to guide its response.

New GIRL Center Research Challenges Key Assumptions on the Links Between Education and Girls’ Health and Well-being

Researchers address what happens to girls’ literacy and numeracy skills when they leave school and have their first baby.

Phase 3 Results Show Population Council’s One-Year Contraceptive Vaginal System Highly Effective

Annovera™ provides a full year of protection against unintended pregnancy while fully under a woman’s control.

Population Council to Determine Feasibility of Fast-Tracking Oral Contraceptive Multipurpose Prevention Technology (cMPT) Development

Women may be more likely to use an HIV prevention method if it also protects against pregnancy.

New Research on Griffithsin and Carageenan to Prevent HIV and STIs Published in Nature Communications

Research shows that it may be possible to formulate a discreet, convenient, woman-controlled multipurpose technology.